-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Maintains Buy on Bioventus, Raises Price Target to $16

Benzinga·03/06/2026 18:03:47
Listen to the news
Craig-Hallum analyst Alexander Nowak maintains Bioventus (NASDAQ:BVS) with a Buy and raises the price target from $15 to $16.